Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hydrophilic Radiopaque Microsphere With Doxorubicin for Hepatoma Embolization Therapy

NCT03299036 is registered in ClinicalTrials.gov with National Cheng-Kung University Hospital as lead sponsor.

NCT NCT03299036
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03299036 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hydrophilic Radiopaque Microsphere With Doxorubicin for Hepatoma Embolization Therapy
Lead sponsor
National Cheng-Kung University Hospital
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2017
Completion date
October 16, 2018
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of liver